Product NewsDrug discovery > Lead Discovery CeNeS strengthens the patent portfolio for its lead clinical programme M6G (morphine-6-glucuronide)
Product NewsDrug discovery > Clinical Development CeNeS announces the publication of an important independent review of its lead product, M6G